FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210888970> ?p ?o ?g. }

• W4210888970 endingPage "1731" @default.
• W4210888970 startingPage "1717" @default.
• W4210888970 abstract "Aim: This subanalysis of the CAVIDIOPAL study evaluated the impact of individualized management of breakthrough cancer pain (BTcP) with fentanyl on the quality of life (QoL) of advanced cancer patients in Spanish palliative care units. Patients & methods: This was a prospective, observational, multicenter study. The European Organization for Research and Treatment of Cancer's QLQ-C30 questionnaire was used at baseline (V0) and visit 28 (V28). Results: Ninety-five patients were mainly treated with 67-133 μg fentanyl, showing a notable reduction in intensity (visual analog scale: 8.0 [V0] to 4.6 [V28]), frequency and duration of BTcP episodes shortly after the first 1-2 weeks of treatment, with significantly improved QoL (global health status: 31.1 [V0] to 53.1 [V28]). Conclusion: Low-dose sublingual fentanyl effectively reduced BTcP in advanced cancer patients in palliative care units, significantly improving QoL. Clinical trial registration: NCT02840500 (ClinicalTrials.gov).After the CAVIDIOPAL study, we carried out an additional analysis to evaluate the impact of individualized management of breakthrough cancer pain, using the analgesic drug fentanyl, on quality of life (QoL) of advanced cancer patients receiving palliative care in Spain. We performed a prospective, observational, multicenter study, in which patients’ QoL was assessed using a validated questionnaire at baseline (day 0) and after 28 days of fentanyl treatment. Of the 95 patients included in the study, the majority were treated with low doses of fentanyl and showed significant pain relief. The intensity, frequency and duration of breakthrough cancer pain episodes were notably reduced shortly after the first 1–2 weeks of treatment. Moreover, patients’ QoL significantly improved during fentanyl treatment from baseline to day 28. A global impression of improvement was reported by both patients and clinicians." @default.
• W4210888970 created "2022-02-09" @default.
• W4210888970 creator A5001283496 @default.
• W4210888970 creator A5010624639 @default.
• W4210888970 creator A5029117634 @default.
• W4210888970 creator A5037682827 @default.
• W4210888970 creator A5043098865 @default.
• W4210888970 creator A5068377444 @default.
• W4210888970 creator A5069679368 @default.
• W4210888970 creator A5082204333 @default.
• W4210888970 creator A5091036584 @default.
• W4210888970 date "2022-05-01" @default.
• W4210888970 modified "2023-09-27" @default.
• W4210888970 title "Low-dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain in palliative care" @default.
• W4210888970 cites W1122399893 @default.
• W4210888970 cites W1479801386 @default.
• W4210888970 cites W1494229485 @default.
• W4210888970 cites W161235706 @default.
• W4210888970 cites W1979832704 @default.
• W4210888970 cites W1980842104 @default.
• W4210888970 cites W1987318150 @default.
• W4210888970 cites W1994970316 @default.
• W4210888970 cites W2000445173 @default.
• W4210888970 cites W2001086017 @default.
• W4210888970 cites W2003064100 @default.
• W4210888970 cites W2023183852 @default.
• W4210888970 cites W2024154885 @default.
• W4210888970 cites W2062687109 @default.
• W4210888970 cites W2102114446 @default.
• W4210888970 cites W2142446315 @default.
• W4210888970 cites W2150311669 @default.
• W4210888970 cites W2162296777 @default.
• W4210888970 cites W2171488949 @default.
• W4210888970 cites W2211574672 @default.
• W4210888970 cites W2398549051 @default.
• W4210888970 cites W2462340510 @default.
• W4210888970 cites W2737444063 @default.
• W4210888970 cites W2769448136 @default.
• W4210888970 cites W2773706811 @default.
• W4210888970 cites W2791194683 @default.
• W4210888970 cites W2805632991 @default.
• W4210888970 cites W2806875460 @default.
• W4210888970 cites W2834719472 @default.
• W4210888970 cites W2886642120 @default.
• W4210888970 cites W2892659800 @default.
• W4210888970 cites W2896143462 @default.
• W4210888970 cites W2897699581 @default.
• W4210888970 cites W2915336383 @default.
• W4210888970 cites W2942311506 @default.
• W4210888970 cites W2949396185 @default.
• W4210888970 cites W2951427521 @default.
• W4210888970 cites W2965437454 @default.
• W4210888970 cites W2991146986 @default.
• W4210888970 cites W3110968266 @default.
• W4210888970 cites W3126281255 @default.
• W4210888970 cites W4241184656 @default.
• W4210888970 cites W4376595560 @default.
• W4210888970 doi "https://doi.org/10.2217/fon-2021-1639" @default.
• W4210888970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35137627" @default.
• W4210888970 hasPublicationYear "2022" @default.
• W4210888970 type Work @default.
• W4210888970 citedByCount "1" @default.
• W4210888970 countsByYear W42108889702022 @default.
• W4210888970 crossrefType "journal-article" @default.
• W4210888970 hasAuthorship W4210888970A5001283496 @default.
• W4210888970 hasAuthorship W4210888970A5010624639 @default.
• W4210888970 hasAuthorship W4210888970A5029117634 @default.
• W4210888970 hasAuthorship W4210888970A5037682827 @default.
• W4210888970 hasAuthorship W4210888970A5043098865 @default.
• W4210888970 hasAuthorship W4210888970A5068377444 @default.
• W4210888970 hasAuthorship W4210888970A5069679368 @default.
• W4210888970 hasAuthorship W4210888970A5082204333 @default.
• W4210888970 hasAuthorship W4210888970A5091036584 @default.
• W4210888970 hasBestOaLocation W42108889701 @default.
• W4210888970 hasConcept C121608353 @default.
• W4210888970 hasConcept C126322002 @default.
• W4210888970 hasConcept C14184104 @default.
• W4210888970 hasConcept C159110408 @default.
• W4210888970 hasConcept C1862650 @default.
• W4210888970 hasConcept C188816634 @default.
• W4210888970 hasConcept C23131810 @default.
• W4210888970 hasConcept C2778904085 @default.
• W4210888970 hasConcept C2779526319 @default.
• W4210888970 hasConcept C2779951463 @default.
• W4210888970 hasConcept C2780052408 @default.
• W4210888970 hasConcept C2780820201 @default.
• W4210888970 hasConcept C2781072394 @default.
• W4210888970 hasConcept C2781118164 @default.
• W4210888970 hasConcept C2991975920 @default.
• W4210888970 hasConcept C2994186709 @default.
• W4210888970 hasConcept C42219234 @default.
• W4210888970 hasConcept C71924100 @default.
• W4210888970 hasConceptScore W4210888970C121608353 @default.
• W4210888970 hasConceptScore W4210888970C126322002 @default.
• W4210888970 hasConceptScore W4210888970C14184104 @default.
• W4210888970 hasConceptScore W4210888970C159110408 @default.
• W4210888970 hasConceptScore W4210888970C1862650 @default.
• W4210888970 hasConceptScore W4210888970C188816634 @default.

• next